v3.26.1
Segments - Schedule of financial data for the company's reportable segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Personnel-related indirect research and development expenses $ 1,266   $ 1,241   $ 2,577 $ 2,501
Total general and administrative expenses 2,442   2,714   5,095 5,402
Other segment items [1] 780   725   1,451 1,646
Segment net loss 4,781 $ 5,090 5,094 $ 5,550 9,871 10,644
INB-100            
Segment Reporting [Line Items]            
Segment research and development expenses 245   228   623 454
INB-200            
Segment Reporting [Line Items]            
Segment research and development expenses 21   5   57 15
INB-400            
Segment Reporting [Line Items]            
Segment research and development expenses $ 27   $ 181   $ 68 $ 626
[1] Other segment items include preclinical expenses, interest income and other income.